These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28926061)

  • 21. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
    Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
    EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional flexibility of human cyclin-dependent kinase-2 and its evolutionary conservation.
    Bártová I; Koca J; Otyepka M
    Protein Sci; 2008 Jan; 17(1):22-33. PubMed ID: 18042686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma.
    Matsumoto M; Furihata M; Ishikawa T; Ohtsuki Y; Ogoshi S
    Br J Cancer; 1999 Apr; 80(1-2):256-61. PubMed ID: 10390005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why pyridine containing pyrido[2,3-d]pyrimidin-7-ones selectively inhibit CDK4 than CDK2: insights from molecular dynamics simulation.
    Mascarenhas NM; Bhattacharyya D; Ghoshal N
    J Mol Graph Model; 2010 Apr; 28(7):695-706. PubMed ID: 20153225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective anticancer activity of a hexapeptide with sequence homology to a non-kinase domain of Cyclin Dependent Kinase 4.
    Warenius HM; Kilburn JD; Essex JW; Maurer RI; Blaydes JP; Agarwala U; Seabra LA
    Mol Cancer; 2011 Jun; 10():72. PubMed ID: 21668989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities.
    He G; Siddik ZH; Huang Z; Wang R; Koomen J; Kobayashi R; Khokhar AR; Kuang J
    Oncogene; 2005 Apr; 24(18):2929-43. PubMed ID: 15735718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix.
    Fraedrich K; Müller B; Grassmann R
    Retrovirology; 2005 Sep; 2():54. PubMed ID: 16164752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
    Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
    Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3D-QSAR CoMFA study on indenopyrazole derivatives as cyclin dependent kinase 4 (CDK4) and cyclin dependent kinase 2 (CDK2) inhibitors.
    Singh SK; Dessalew N; Bharatam PV
    Eur J Med Chem; 2006 Nov; 41(11):1310-9. PubMed ID: 16890327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limited redundancy in phosphorylation of retinoblastoma tumor suppressor protein by cyclin-dependent kinases in acute lymphoblastic leukemia.
    Schmitz NM; Hirt A; Aebi M; Leibundgut K
    Am J Pathol; 2006 Sep; 169(3):1074-9. PubMed ID: 16936279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of the surface interaction properties of the binding sites of CDK2, CDK4, and ERK2.
    Kelly MD; Mancera RL
    ChemMedChem; 2006 Mar; 1(3):366-75. PubMed ID: 16892371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lys61]N-Ras is able to induce full activation and nuclear accumulation of Cdk4 in NIH3T3 cells.
    Villalonga P; Rius E; Bachs O; Agell N
    Oncogene; 2000 Feb; 19(5):690-9. PubMed ID: 10698514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21.
    Colleoni B; Paternot S; Pita JM; Bisteau X; Coulonval K; Davis RJ; Raspé E; Roger PP
    Oncogene; 2017 Jul; 36(30):4349-4361. PubMed ID: 28368408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and biological study of novel pyrido[2,3-d]pyrimidine as anti-proliferative CDK2 inhibitors.
    Ibrahim DA; Ismail NS
    Eur J Med Chem; 2011 Dec; 46(12):5825-32. PubMed ID: 22000924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring Molecular Mechanisms of Paradoxical Activation in the BRAF Kinase Dimers: Atomistic Simulations of Conformational Dynamics and Modeling of Allosteric Communication Networks and Signaling Pathways.
    Tse A; Verkhivker GM
    PLoS One; 2016; 11(11):e0166583. PubMed ID: 27861609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-based network analysis of activation mechanisms in the ErbB family of receptor tyrosine kinases: the regulatory spine residues are global mediators of structural stability and allosteric interactions.
    James KA; Verkhivker GM
    PLoS One; 2014; 9(11):e113488. PubMed ID: 25427151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of novel nonpeptide allosteric inhibitors interrupting the interaction of CDK2/cyclin A3 by virtual screening and bioassays.
    Hu Y; Li S; Liu F; Geng L; Shu X; Zhang J
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4069-73. PubMed ID: 26316466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal structure of human CDK4 in complex with a D-type cyclin.
    Day PJ; Cleasby A; Tickle IJ; O'Reilly M; Coyle JE; Holding FP; McMenamin RL; Yon J; Chopra R; Lengauer C; Jhoti H
    Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4166-70. PubMed ID: 19237565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.